245 related articles for article (PubMed ID: 7775260)
1. Do structural changes of T cell receptor complex occur in tumor-bearing state?
Noda S; Nagata-Narumiya T; Kosugi A; Narumiya S; Ra C; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1995 Apr; 86(4):383-94. PubMed ID: 7775260
[TBL] [Abstract][Full Text] [Related]
2. CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn.
Burgess KE; Yamamoto M; Prasad KV; Rudd CE
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9311-5. PubMed ID: 1384049
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of T cell dysfunction in cancer is influenced by the paracrine secretion of tumor-derived IL-2.
Salvadori S; Zier K
J Immunol; 1996 Apr; 156(8):2927-32. PubMed ID: 8609413
[TBL] [Abstract][Full Text] [Related]
4. T cells from late tumor-bearing mice express normal levels of p56lck, p59fyn, ZAP-70, and CD3 zeta despite suppressed cytolytic activity.
Levey DL; Srivastava PK
J Exp Med; 1995 Oct; 182(4):1029-36. PubMed ID: 7561676
[TBL] [Abstract][Full Text] [Related]
5. CD3-zeta surface expression is required for CD4-p56lck-mediated upregulation of T cell antigen receptor-CD3 signaling in T cells.
Sancho J; Ledbetter JA; Choi MS; Kanner SB; Deans JP; Terhorst C
J Biol Chem; 1992 Apr; 267(11):7871-9. PubMed ID: 1532798
[TBL] [Abstract][Full Text] [Related]
6. The p56lck SH2 domain mediates recruitment of CD8/p56lck to the activated T cell receptor/CD3/zeta complex.
Thome M; Germain V; DiSanto JP; Acuto O
Eur J Immunol; 1996 Sep; 26(9):2093-2100. PubMed ID: 8814252
[TBL] [Abstract][Full Text] [Related]
7. T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present.
Wang Q; Stanley J; Kudoh S; Myles J; Kolenko V; Yi T; Tubbs R; Bukowski R; Finke J
J Immunol; 1995 Aug; 155(3):1382-92. PubMed ID: 7636203
[TBL] [Abstract][Full Text] [Related]
8. Abnormal signal transduction by T cells of mice with parental tumors is not seen in mice bearing IL-2-secreting tumors.
Salvadori S; Gansbacher B; Pizzimenti AM; Zier KS
J Immunol; 1994 Dec; 153(11):5176-82. PubMed ID: 7963575
[TBL] [Abstract][Full Text] [Related]
9. Syk and ZAP-70 mediate recruitment of p56lck/CD4 to the activated T cell receptor/CD3/zeta complex.
Thome M; Duplay P; Guttinger M; Acuto O
J Exp Med; 1995 Jun; 181(6):1997-2006. PubMed ID: 7539035
[TBL] [Abstract][Full Text] [Related]
10. CD4-dependent and -independent association of protein tyrosine kinases to the T cell receptor/CD3 complex of CD4+ mouse T lymphocytes.
Criado G; Feito MJ; Rojo JM
Eur J Immunol; 1996 Jun; 26(6):1228-34. PubMed ID: 8647197
[TBL] [Abstract][Full Text] [Related]
11. MHC class I ligation of human T cells activates the ZAP70 and p56lck tyrosine kinases, leads to an alternative phenotype of the TCR/CD3 zeta-chain, and induces apoptosis.
Skov S; Bregenholt S; Claesson MH
J Immunol; 1997 Apr; 158(7):3189-96. PubMed ID: 9120273
[TBL] [Abstract][Full Text] [Related]
12. The implications of subunit interactions for the structure of the T cell receptor-CD3 complex.
Koning F; Maloy WL; Coligan JE
Eur J Immunol; 1990 Feb; 20(2):299-305. PubMed ID: 2138083
[TBL] [Abstract][Full Text] [Related]
13. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice.
Mizoguchi H; O'Shea JJ; Longo DL; Loeffler CM; McVicar DW; Ochoa AC
Science; 1992 Dec; 258(5089):1795-8. PubMed ID: 1465616
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation and coupling of zeta-chains to activated T-cell receptor (TCR)/CD3 complexes from peripheral blood T-cells of elderly humans.
Whisler RL; Karanfilov CI; Newhouse YG; Fox CC; Lakshmanan RR; Liu B
Mech Ageing Dev; 1998 Sep; 105(1-2):115-35. PubMed ID: 9922123
[TBL] [Abstract][Full Text] [Related]
15. Rapid turnover of the CD3 zeta chain independent of the TCR-CD3 complex in normal T cells.
Ono S; Ohno H; Saito T
Immunity; 1995 Jun; 2(6):639-44. PubMed ID: 7796297
[TBL] [Abstract][Full Text] [Related]
16. T cell receptor complexes containing Fc epsilon RI gamma homodimers in lieu of CD3 zeta and CD3 eta components: a novel isoform expressed on large granular lymphocytes.
Koyasu S; D'Adamio L; Arulanandam AR; Abraham S; Clayton LK; Reinherz EL
J Exp Med; 1992 Jan; 175(1):203-9. PubMed ID: 1530959
[TBL] [Abstract][Full Text] [Related]
17. TCR-gamma delta cells in CD3 zeta-deficient mice contain Fc epsilon RI gamma in the receptor complex but are specifically unresponsive to antigen.
Khattri R; Sperling AI; Qian D; Fitch FW; Shores EW; Love PE; Bluestone JA
J Immunol; 1996 Sep; 157(6):2320-7. PubMed ID: 8805629
[TBL] [Abstract][Full Text] [Related]
18. Both T cell receptor (TcR)-CD3 complex and CD2 increase the tyrosine kinase activity of p56lck. CD2 can mediate TcR-CD3-independent and CD45-dependent activation of p56lck.
Danielian S; Alcover A; Polissard L; Stefanescu M; Acuto O; Fischer S; Fagard R
Eur J Immunol; 1992 Nov; 22(11):2915-21. PubMed ID: 1358625
[TBL] [Abstract][Full Text] [Related]
19. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase.
Bottino C; Vitale M; Olcese L; Sivori S; Morelli L; Augugliaro R; Ciccone E; Moretta L; Moretta A
Eur J Immunol; 1994 Oct; 24(10):2527-34. PubMed ID: 7523145
[TBL] [Abstract][Full Text] [Related]
20. Changes in arrangement and in conformation of molecular components of peripheral T-cell antigen receptor complex after ligand binding: analyses by co-precipitation profiles.
Osono E; Sato N; Yokomuro K; Saizawa MK
Scand J Immunol; 1997 May; 45(5):487-93. PubMed ID: 9160091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
